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1. Introduction 
Thioredoxin is a widely distributed hydrogen 
transport protein which has been purified to homo- 
geneity from bacteria, yeast and bovine liver [l-3] . 
This small protein operates via a reversible dithiol- 
disulfide mechanism and carries hydrogen from 
NADPH to enzymatic reduction processes like the 
formation of deoxyribonucleotides [4]. Thioredoxin 
from Escherichia coli is composed of a single poly- 
peptide chain having 108 amino acid residues of 
known amino acid sequence [ 51. The three-dimensional 
structure of oxidized thioredoxin to 2.8 A resolution 
by X-ray crystallography [6] has been determined. 
The functional part of the molecule is formed from 
two vicinal half-cystine residues (Cys-32 and Cys-35) 
which in the oxidized protein forms a disulfide, 
located in a protrusion of the molecule [6]. 
A localized conformational change in E. coli thio- 
redoxin takes place upon chemical or enzymatical 
reduction of the oxidized form (thioredoxin-Sz) to 
give the reduced form (thioredoxin-(SI-& [7]. 
This conformational change was first demonstrated 
by the more than 3-fold increase in fluorescence 
quantum yield of tryptophan emission of the protein 
upon reduction [7]. It was subsequently shown that 
the two tryptophan residues (Trp-28 and Trp-31) 
both are close to the disulfide bridge in the primary 
structure of the protein [5]. Further studies of the 
tryptophan fluorescence of E. coli and the homo- 
logous yeast thioredoxin with a single tryptophan 
residue [8] indicated that the large increase upon 
reduction of the E. coli protein was a major change 
in the fluorescence quantum yield of only Trp-28 
due to different microenvironment in oxidized and 
reduced E. coli thioredoxin [9,10]. 
The present paper describes PMR spectra of oxidized 
and reduced thioredoxin in Hz0 and D20. The con- 
formational differences of oxidized and reduced thio- 
redoxin appear small at pH above 7.0 but become 
appreciable at lower pH. The reduced form of thio- 
redoxin was less stable at pH values below 7.0 and 
aggregated reversibly close to the isoelectric point. 
Proton nuclear magnetic resonance spectra of thio- 
redoxin in Hz0 led to the identification of two 
resonance peaks from the indole NH proton of the 
two tryptophan residues of the molecule. Upon reduc- 
tion of oxidized thioredoxin only one of these two 
peaks showed a major change in chemical shift while 
both peaks shifted as a function of pH. 
2. Materials and methods 
Thioredoxin from E. coli B 3 was prepared as 
described previously (Method 2) [ 1 l] and was of 
better than 98% purity. The sample of thioredoxin 
(5.7 pmol, 67 mg) to be used in the NMR experi- 
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ments was lyophilized from 0.2% N&HCOa, pH 8.0 
and dissolved in 1.5 ml of 0.1 M sodium phosphate 
buffer in DaO, pH* 7.0 and lyophilized again. The 
dry residue was dissolved in 1.5 ml of DzO, giving 
a final concentration of 3.7 mM and transferred to 
the NMR probe tube. Dioxane was added as an internal 
reference to give a final concentration of 2 mM. 
Determinations of pH were performed with a 
Radiometer pHM 26 pH-meter and a Beckman com- 
bination electrode type 39030. The pH-determination 
in DzO solutions is given as pH*, which is the direct 
pH meter reading, uncorrected for the isotope effect 
on the glass electrode. pH* was lowered using small 
aliquots of 2 M DC1 and raised by addition of 1 .O M 
NaOD. pH*-measurements during PMR titration curves 
of thioredoxin were made before and after the spec- 
trum was obtained and refer to the temperature of 
the probe, 27.5 + 05°C. 
The PMR spectra of thioredoxin were recorded at 
100 MHz. Those in Da0 were recorded on a Varian 
XL1 00-l 5 spectrometer in the Fourier transform 
mode, those in HZ0 on a Varian HA-100 spectrometer 
coupled to a Biomac computer of average transitions. 
Field-frequency lock was obtained from the proton 
resonance of a hexamethyldisiloxane capillary. 
Reduction of thioredoxin-Sz was achieved by the 
addition of approximately 12-fold molar excess 
(10 mg) of recrystallized dithiothreitol (Calbiochem. 
A.G.). 
3. Results and discussion 
3.1. Proton magnetic resonance spectra in D20 
We have here concentrated on the region between 
-6.5 and -9.0 ppm which contains the protons of 
the aromatic amino acid residues and histidineC2 
protons [ 121. Thioredoxin contains two tryptophan 
residues (Trp-28 and Trp-31), four phenylalanine 
residues (Phe-12, Phe-27, Phe-81, and Phe-102) two 
tyrosine residues (Tyr-49 and Tyr-70) and one histidine 
residue (His-6). These amino acid residues cover the 
entire primary structure of the protein, and can thus 
be regarded as convenient reporter groups of the con- 
formation of various parts of the molecule. 
PMR spectra of the aromatic region of thioredoxin- 
SZ recorded at different pH*-values are shown in fig. 1. 
The spectrum showed the same overall appearance at 
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Chemical shift ink from HMS reference 
Fig.1. 100 MHz proton NMR spectrum of oxidized and 
reduced I$ 
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His-6 is part of a P-pleated sheet strand at the top of 
the molecule with its side chain exposed, which thus 
agree with the measured pK value. 
The spectrum at pH* 4.75 was significantly different 
from those at higher pH*, and indicated the beginning 
of a reversible acid unfolding of thioredoxin at this pH*. 
This acid unfolding of thioredoxin has not been 
previously observed since tryptophan fluorescence 
spectra of thioredoxin-Ss showed the same strongly 
quenched emission from pH 2 to pH 10 [9]. The 
isoelectric point of thioredoxin has been determined 
to be pH 4.5; (1) pH* 4.70 is equivalent to pD 5.1. At 
room temperature, therefore, the acid unfolding of thio- 
redoxin was observed somewhat above the isoelectric 
point. 
A comparison of the proton NMR spectra of thio- 
redoxin& and chemically reduced thioredoxin-(SH)2 
at pH* ~8 is shown in fig. 1. Only minor differences 
were noted indicating very similar overall conforma- 
tions of oxidized and reduced thioredoxin at this pH*, 
strongly supporting a minor local conformational 
change upon oxidoreduction. In contrast to thio- 
redoxir&, however, the reduced protein showed 
spectral shifts of the aromatic region between pH* 8.0 
and 5.5 indicating considerably less stability to changes 
in pH*. At pH* 5.7-6.0 there were clearly appreciable 
differences in the spectra of the two forms. This is in 
agreement with the marked changes in tryptophan 
fluorescence observed for reduced thioredoxin at 
pH 2.0-8.0 [9]. 
At pH* 4.60 the spectrum of thioredoxin-(SH)2 
was seriously broadened and uncharacteristic indicating 
considerable aggregation. At the same time the solu- 
tion of the protein turned cloudy. By titrating the 
solution back to pH 9.0 the cloudiness disappeared and 
the spectrum of the aromatic region was again identical 
with that previously observed at pH* 8.08. These 
results which demonstrate a reversible aggregation of 
thioredoxin-(SH)z at acidic pH are in agreement with 
previous results from ultracentrifugation studies [l] 
of p-mercuribenzoate-treated thioredoxin-(SH)2. 
Earlier attempts to reverse the aggregation at pH 7.0 
resulted in partial deaggregation [1 ] ; obviously pH 9.0 
is necessary to complete this process. The unfolding 
and aggregation at low pH made it impossible to deter- 
mine the pK of His-6 in the reduced protein. Compa- 
rison of its position in the spectra of the two forms 
at pH* ‘L 6, however, suggested little change in PK. 
The results of NMR-studies here indicate consider- 
able differences in the conformation of oxidized and 
reduced thioredoxin at pH-values close to the iso- 
electric point. This result is important, since attempts 
to obtain crystals of the reduced form of thioredoxin 
by diffusing thiols into preformed crystals at 4°C 
close to pH 4.7 ([ 141 Holmgren, A., unpublished 
results) have led to destruction of the crystals. If the 
conformational differences between oxidized and 
reduced thioredoxin are large at low pH, they might 
not be positioned in the same crystal lattice. 
3.2. Proton magnetic resonance spectra in Hz0 
In the proton magnetic resonance spectra of 
thioredoxin& and thioredoxin-(SH)2 in HzO, two 
separate peaks corresponding to indole NH resonances 
of tryptophan could be identified between -11 .O and 
-12.0 ppm from external HMS (frg.2). The chemical 
Thiordoxin-!+ 
pH 6.90 
y?f”-vJf 
450 -1;OO -1150 -n’oo -1Lkl 
Chemical shift in Hz from HMS reference 
F&2. 100 mHz proton NMR spectra of thioredoxin-S, and 
thioredoxin-(SH), in, H,O at different pH values. Chemical 
shifts refer to Hz downfield of external HMS. 
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Table 1 
Chemical shifts of NH-indole peaks of thioredoxin in H,Oa 
Thioredoxin-S,, pH 6.90 
Thioredoxin-(SH),, pH 8.30 
Thioredoxin-S, pH 5.48 
Thioredoxin-(SH),, pR 5.30 
Low field peak 
-1194Hz 
- 1182 Hz 
-1186Hz 
- 1176 Hz 
High field peak 
- 1121 Hz 
-1117Hz 
- 1107 Hz 
- 1106 Hz 
aChemical shifts are expressed as Hz downfield from external HMS. 
shifts of the resonances are summarized in table 1. 
The low field peak at -11.94 ppm from HMS in 
thioredoxin& moves approximately 0.12 ppm upfield 
upon reduction to thioredoxin-(SH)Z. The high field 
peak at - 11.21 ppm in thioredoxinSa on the other 
hand moves only 0.04 ppm upon reduction. 
When spectra of thioredoxin-Sa and thioredoxin- 
(SH), were recorded at lower pH* both the high field 
and low field peaks had moved approximately 0.1 ppm 
downfield. Again at the lower pH*, reduction of 
thioredoxin-Sa leads to an uptield shift of 0.10 ppm 
of the resonance at lower field, while that at - 11.06 ppm 
is unaffected. 
These observations indicate that the two tryptophan 
residues of thioredoxin, though very close in the 
sequence, have quite distinct environments in both the 
oxidized and reduced protein. Reduction of thio- 
redoxin-Sa affects one of the peaks appreciably more 
than the other; it is tempting to suggest hat the local 
conformational change in thioredoxin on reduction 
changes the environment around one of the tryptophan 
residues. It is not known if this residue is the same as 
that observed by the fluorescence spectroscopy [9,10]. 
It is notable that the chemical shifts of both these 
two indole NH resonances are equally pH-dependent, 
and that both oxidized and reduced forms of the 
protein show essentially the same pH dependence. 
This is in contrast to the finding, discussed above, that 
the pH-dependence of the overall conformation is 
quite different in the two forms, From the three- 
dimensional structure.of thioredoxin_Sa [6], Trp31 
is part of a protrusion formed by residues 29-37 
containing the oxidation reduction active disulfide 
bond. Trp-31 is completely exposed to solvent whereas 
the other tryptophan residue, Trp-28 is partly shielded 
by a pleated sheet. The fluorescence of both tryptophan 
residues have been proposed to be quenched by the 
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disulfide bond in thioredoxm& [9]. The exact nature 
of the conformational change occurring in the active 
site protrusion upon reduction of thioredoxin-Sz is 
not known. Further NMR studies of chemically 
modified thioredoxin [lo] may be valuable to define 
more closely the nature of the conformational change 
which is part of the oxidation-reduction function in 
the thioredoxin-molecule. 
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